Frenchman Hadjar said he was surprised to be third, expecting Ferrari to be ahead of him, but on his debut for the Red Bull team he did what so many of his predecessors could not and delivered when Verstappen hit trouble. The four-time champion spun off and crashed at Turn One on his first lap of the session when his rear axle locked, catching him by surprise. He was shaking his hands after he cli...
Frenchman Hadjar said he was surprised to be third, expecting Ferrari to be ahead of him, but on his debut for the Red Bull team he did what so many of his predecessors could not and delivered when Verstappen hit trouble. The four-time champion spun off and crashed at Turn One on his first lap of the session when his rear axle locked, catching him by surprise. He was shaking his hands after he climbed out of the car, because he had held on to the steering wheel on impact, but said nothing was broken. "I have no idea (what happened)," he said. "I just arrived to Turn One and the rear axle just completely locked up out of the blue while hitting the pedal, so this is something very weird that I've never experienced in F1 before. So just need to understand what went wrong." He will start 20th, ahead only of the Williams of Carlos Sainz and Aston Martin of Lance Stroll, neither of whom were able to take part in the session after reliability problems in final practice. Behind the Racing Bulls, the new Audi team had a strong session with Gabriel Bortoleto and Nico Hulkenberg taking 10th and 11th places, with the Haas cars of Oliver Bearman and Esteban Ocon 12th and 13th. Bortoleto missed a chance to start higher because his car broke down on the way back to the pits after the second knockout session. Alonso took the opportunity to underline how much difference finally managing to complete some laps had made to a team that were five seconds off the pace on Friday by reducing that to 2.5secs in qualifying. "The whole winter has been a little bit with that feeling that there is much more to come, especially on the chassis side," he told BBC Radio 5 Live. "We feel more or less OK in the corners and we feel we could be in the top 10 easily and then we cannot put laps together in the winter. "Here, thanks to a more normal second and third practice, we found two seconds easily just because we ran. "It is a matter of continuing to do laps and stay united. There is no secret that t...
Fintel reports that on March 5, 2026, Evercore ISI Group upgraded their outlook for Southern Company - Corporate Bond (NYSE:SOJD) from In-Line to Outperform. Analyst Price Forecast Suggests 4.90% Upside As of February 25, 2026, the average one-year price target for Southern Company - Corporate Bond is $21.87/share. The forecasts range from a low of $16.43 to a high of $24.75. The average price tar...
Fintel reports that on March 5, 2026, Evercore ISI Group upgraded their outlook for Southern Company - Corporate Bond (NYSE:SOJD) from In-Line to Outperform. Analyst Price Forecast Suggests 4.90% Upside As of February 25, 2026, the average one-year price target for Southern Company - Corporate Bond is $21.87/share. The forecasts range from a low of $16.43 to a high of $24.75. The average price target represents an increase of 4.90% from its latest reported closing price of $20.85 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Southern Company - Corporate Bond is 30,106MM, an increase of 1.87%. The projected annual non-GAAP EPS is 4.67. What is the Fund Sentiment? There are 15 funds or institutions reporting positions in Southern Company - Corporate Bond. This is an decrease of 21 owner(s) or 58.33% in the last quarter. Average portfolio weight of all funds dedicated to SOJD is 0.17%, an increase of 54.49%. Total shares owned by institutions decreased in the last three months by 90.81% to 841K shares. What are Other Shareholders Doing? HDBFX - Hartford Dynamic Bond Fund Class F holds 220K shares. In its prior filing, the firm reported owning 90K shares , representing an increase of 59.09%. The firm increased its portfolio allocation in SOJD by 102.46% over the last quarter. FPE - First Trust Preferred Securities and Income ETF holds 180K shares. In its prior filing, the firm reported owning 95K shares , representing an increase of 47.08%. The firm increased its portfolio allocation in SOJD by 81.62% over the last quarter. John Hancock Preferred Income Fund Iii holds 120K shares. No change in the last quarter. John Hancock Preferred Income Fund holds 110K shares. No change in the last quarter. John Hancock Preferred Income Fund Ii holds 86K shares. No change in the last quarter. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial adv...
The Chinese University of Hong Kong (CUHK) has suspended an academic who reportedly pleaded guilty to posing as a schoolboy to photograph pupils at an elite boys’ school in Australia. Australian media reported that Johnny Li Siu-hang, a professor at CUHK’s business school, was arrested on Tuesday after allegedly dressing in the uniform of the Sydney institution to mingle with pupils and take photo...
The Chinese University of Hong Kong (CUHK) has suspended an academic who reportedly pleaded guilty to posing as a schoolboy to photograph pupils at an elite boys’ school in Australia. Australian media reported that Johnny Li Siu-hang, a professor at CUHK’s business school, was arrested on Tuesday after allegedly dressing in the uniform of the Sydney institution to mingle with pupils and take photos of them. A CUHK spokeswoman said on Friday evening that the university was aware of the incident and attached great importance to it, stressing that it took the conduct of its faculty and staff seriously. Advertisement “The university has suspended the duties of the faculty member concerned and will set up a committee to investigate the incident in accordance with relevant procedures,” she said. “Any breach of conduct will be handled seriously.” The professor was also reported to have visited the campuses of four of Sydney’s top high schools. Photo: Handout Australian media earlier reported that the 46-year-old professor had been mingling with students playing at a public park opposite their school, when a teacher spotted and “extracted” him from the crowd of high-school boys.
To activate the text-to-speech service, please first agree to the privacy policy below. Taipei, March 7 (CNA) Taiwan Semiconductor Manufacturing Co. (TSMC) said Saturday the company aims to hire 8,000 more employees this year to meet its expansion needs, and plans to pay an average annual salary of NT$2.2 million (US$69,449) to new engineers holding a master's degree. The world's largest contract ...
To activate the text-to-speech service, please first agree to the privacy policy below. Taipei, March 7 (CNA) Taiwan Semiconductor Manufacturing Co. (TSMC) said Saturday the company aims to hire 8,000 more employees this year to meet its expansion needs, and plans to pay an average annual salary of NT$2.2 million (US$69,449) to new engineers holding a master's degree. The world's largest contract chipmaker said it has launched a recruitment campaign in Taiwan, including a job fair held at National Taiwan University (NTU) on Saturday. TSMC said the new hires, including engineers and technical staff, will be stationed in its plants in Taoyuan, Hsinchu, Miaoli, Taichung, Chiayi, Tainan and Kaohsiung. The chipmaker said it needs professionals in a wide range of areas, such as electrical engineering, electronics, optoelectronics, physics, materials, chemical engineering, mechanical engineering, environmental engineering, industrial engineering, engineering management, business management, human resources, and accounting. In addition, the chipmaker said that due to its efforts to push for digital transformation and AI and big data applications, the company will seek talent in emerging technologies. After the job fair at NTU, TSMC will hold similar events in other universities across Taiwan and five additional online recruitment events. Meanwhile, TSMC also announced an internship program for the upcoming summer vacation and will take applications from students in their third year of university or higher before May 8. It said students studying master's and Ph.D. programs will be prioritized.
Key Points Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effort to generate positive cash flow. 10 stocks we like better than Amarin Plc › Amarin (NASDAQ: AMRN) is a drug company that is in a particularly precarious position. This fact is highlighted by the company's recent move to restructure its operations in an effort to cut costs. And Vascepa, ...
Key Points Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effort to generate positive cash flow. 10 stocks we like better than Amarin Plc › Amarin (NASDAQ: AMRN) is a drug company that is in a particularly precarious position. This fact is highlighted by the company's recent move to restructure its operations in an effort to cut costs. And Vascepa, the one drug it has to sell, is already facing generic competition in the United States. Most investors would be better off with a larger drug company. Amarin has some positives to offer Perhaps the most positive thing about Amarin is its balance sheet. The company is carrying no long-term debt, has a cash balance of nearly $135 million, and owns short-term investments worth just under $168 million. In short, it is in a very strong financial position and can likely sustain its business for years to come. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Meanwhile, despite the headwinds Vascepa faces in the U.S. market, it is a revenue-generating product. In 2025, Amarin had product sales of nearly $183 million. And a restructuring effort in 2025 has helped the company reduce costs. Management believes the restructuring will help it to generate positive free cash flow in 2026. A pharmaceutical company with no debt and positive free cash flow would normally be hard to complain about. I still wouldn't touch Amarin with a 10-foot pole For the most part, the good news ends there. The big risk is that the company's sales stood at $285 million two years ago. So there's been a material decline on the top line. The fact that its only drug has faced generic competition in the U.S. market has a lot to do with the revenue decline. With no other product to lean on, Amarin has little choice but to pull back on spending o...